Nightstar Therapeutics PLC Sponsored ADR

( )
NITE After-Hours: () as of PM
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Health Technology » Pharmaceuticals Major

Company Profile

Nightstar Therapeutics is a clinical-stage gene therapy holding company, which engages in the development and commercializing of gene therapies. Its products include NSR-REP1, a treatment of choroideremia; NSR-RPGR, a treatment of X-linked retinitis pigmentosa; and NSR-003, a treatment of a rare inherited macular dystrophy. The company was founded on July 6, 2017 and is headquartered in London, the United Kingdom.